SARA BIERSCHENK: Open Payments
NPI 1891205191 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 34 payments from 15 companies in 2025. Trend: 2023 $2,942 · 2024 $4,114 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $254 |
| Alnylam Pharmaceuticals Inc. | 2 | $157 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $131 |
| Corcept Therapeutics | 1 | $111 |
| Gilead Sciences, Inc. | 1 | $110 |
| United Therapeutics Corporation | 4 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $105 |
| BridgeBio Pharma, Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $90 |
| Novo Nordisk Inc | 2 | $83 |
Products named: AMVUTTRA, LifeVest, Korlym, Epclusa, Attruby, Wegovy, Tyvaso, REPATHA.
Industry payments across FL — which companies pay providers there.
